Crisugabalin provides significant improvement in average daily pain score and shows promise as a postherpetic neuralgia treatment.
Learn about trigeminal neuralgia diagnosis and treatment options from experts at Naruvi Hospitals, Vellore in a webinar.
Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...
Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...
Join Naruvi Hospitals and The Hindu for a webinar on Trigeminal Neuralgia with expert doctors on November 10. Register now!
The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...
Gracie, a young woman from East Yorkshire, faced a harrowing ordeal when she was diagnosed with a debilitating condition that causes sudden, severe, electric shock-like pain in parts of the face. The ...
The global gamma knife market is on a significant growth trajectory, with market size projections reaching USD 702.5 million by 2033, up from USD 337.7 million in 2023. This robust growth reflects a ...
Healing Edge recognizes that the path to wellness is unique for each individual.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback